These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1285303)

  • 1. Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
    Richman DD
    J Enzyme Inhib; 1992; 6(1):55-64. PubMed ID: 1285303
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
    Boucher CA; O'Sullivan E; Mulder JW; Ramautarsing C; Kellam P; Darby G; Lange JM; Goudsmit J; Larder BA
    J Infect Dis; 1992 Jan; 165(1):105-10. PubMed ID: 1370174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.
    Richman DD; Havlir D; Corbeil J; Looney D; Ignacio C; Spector SA; Sullivan J; Cheeseman S; Barringer K; Pauletti D
    J Virol; 1994 Mar; 68(3):1660-6. PubMed ID: 7509000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Aguiniga E; Halpern J; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):832-8. PubMed ID: 7517448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutations of HIV-1 RT gene isolated from patients treated with AZT].
    Kondo M; Saito T; Ito A; Oka S; Takata N; Imai M
    Kansenshogaku Zasshi; 1993 Mar; 67(3):185-9. PubMed ID: 7683706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
    Sheehy N; Desselberger U
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.
    Larder BA; Kemp SD; Harrigan PR
    Science; 1995 Aug; 269(5224):696-9. PubMed ID: 7542804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
    Muckenthaler M; Gunkel N; Levantis P; Broadhurst K; Goh B; Colvin B; Forster G; Jackson GG; Oxford JS
    J Med Virol; 1992 Feb; 36(2):79-83. PubMed ID: 1374791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
    Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
    FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
    Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
    J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA; Kellam P; Kemp SD
    Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV drug resistance and its genetic basis].
    Tsuchie H; Sakamoto T; Kurimura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():610-4. PubMed ID: 7505854
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV drug resistance.
    Richman DD
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1065-71. PubMed ID: 1503820
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of resistance mutants of viral polymerases.
    Oxford JS; al-Jabri AA; Stein CA; Levantis P
    Methods Enzymol; 1996; 275():555-600. PubMed ID: 9026659
    [No Abstract]   [Full Text] [Related]  

  • 17. A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Merigan TC
    J Infect Dis; 1993 Mar; 167(3):526-32. PubMed ID: 7680058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can combination therapy overcome drug resistance?
    Cohen J
    Science; 1993 May; 260(5112):1258. PubMed ID: 7684162
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance.
    Eastman PS; Boyer E; Mole L; Kolberg J; Urdea M; Holodniy M
    J Clin Microbiol; 1995 Oct; 33(10):2777-80. PubMed ID: 8567926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV isolates arising after prolonged zidovudine therapy.
    Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.